Overview

Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia

Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with statins on cholesterol levels in subjects with hypercholesterolemia
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Treatments:
Atorvastatin
Atorvastatin Calcium
Dihydromevinolin
Fluvastatin
Hydroxymethylglutaryl-CoA Reductase Inhibitors
L 647318
Lovastatin
Pravastatin
Rosuvastatin Calcium
Simvastatin